New year and our 20th Anniversary, Thomas F. Lüscher, pulmonary hypertension

Código QR

New year and our 20th Anniversary, Thomas F. Lüscher, pulmonary hypertension

Guardado en:

Detalles Bibliográficos
Autor principal:	Çetin Erol
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/3f88650d860f43a2b98708fe6b6d6eb9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Energy drinks, pulmonary hypertension, and many more
por: Çetin Erol
Publicado: (2021)

Pulmonary hypertension or cardiology aerobatics
por: I. E. Chazova, et al.
Publicado: (2020)

Pulmonary Hypertension in Heart Failure Patients
por: Sriram D Rao, et al.
Publicado: (2020)

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients
por: Sriram D Rao, et al.
Publicado: (2020)

10th Anniversary of Asia Pacific Stroke Organization: State of Stroke Care and Stroke Research in the Asia Pacific
por: Kay-Sin Tan, et al.
Publicado: (2021)

Progress continues on the management of pulmonary arterial hypertension in pregnancy
por: Hannah Douglas, et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism
por: Elif Sahutoglu, et al.
Publicado: (2021)

GLP-1, SGLT-2, new devices for interventional cardiologists
por: Çetin Erol
Publicado: (2021)

Studies and Reviews on Central Sleep Apnea, Endovascular Therapy, Robotic Surgery, and the associated Clinical and Genetic Characteristics in Cardiology
por: Çetin Erol
Publicado: (2021)

Ramadan, TURKMI, REALITY HF, and so on…0
por: Çetin Erol
Publicado: (2021)

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
por: Çetin Erol
Publicado: (2021)

Colchicine, fragmented QRS, coronavirus disease 2019, and more
por: Çetin Erol
Publicado: (2021)

New impact factor and many new studies
por: Çetin Erol
Publicado: (2021)

Miscellaneous attractive studies
por: Çetin Erol
Publicado: (2021)

ARNI, LBBB, COVID-19 and various other topics
por: Çetin Erol
Publicado: (2021)

Can a patient with pulmonary hypertension travel safely by plane?
por: Berkay Ekici
Publicado: (2021)

Pulmonary hypertension in patients with sarcoidosis: A single-center experience
por: Deniz Kaptan Özen, et al.
Publicado: (2021)

Giant pulmonary artery aneurysm caused by sibutramine-associated pulmonary arterial hypertension: First case in the literature
por: Barkın Kültürsay, et al.
Publicado: (2021)

Ventricular–vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension
por: Rolf M F Berger, et al.
Publicado: (2021)

Sustained response to targeted therapies in a patient with pulmonary hypertension owing to Langerhans cell histiocytosis
por: Aykun Hakgör, et al.
Publicado: (2021)

How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
por: Alper Sarı, et al.
Publicado: (2021)

Impaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?
por: Muhittin Demirel, et al.
Publicado: (2021)

Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry
por: Shun Kohsaka, et al.
Publicado: (2021)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Zoltán Papp, et al.
Publicado: (2020)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Systemic venous hypertension and low output are prevalent at catheterization in adults with pulmonary atresia and intact ventricular septum regardless of repair strategy
por: C. Charles Jain, et al.
Publicado: (2021)

A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines
por: Elena Nardi, et al.
Publicado: (2021)

Liver abnormalities in pulmonary arterial hypertension
por: Nils P. Nickel, et al.
Publicado: (2021)

Systemic arterial properties in pulmonary hypertension
por: Randi Goodman, et al.
Publicado: (2021)

20-year follow up of catheter ablation in patients with Ebstein Anomaly: A single-centre study
por: Sonia Nartowicz, et al.
Publicado: (2021)

Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
por: Mehmet Serdar Küçükoğlu, et al.
Publicado: (2021)

Hypertension and Stroke: Update on Treatment
por: Mauricio Wajngarten, et al.
Publicado: (2019)

Systemic arterial hypertension and flight
por: Kaan Okyay
Publicado: (2021)

The clinical experience of macitentan in pulmonary hypertension in Indian cohort: 12-months follow-up
por: Pankaj Jariwala, et al.
Publicado: (2021)

Electrophysiology’s Identity Crisis: What our Clinical Trials Do and Do Not Say About Us
por: David J Callans, et al.
Publicado: (2020)

Performance of pulmonary embolism severity index in predicting long-term mortality after acute pulmonary embolism
por: Abdulsamet Sandal, et al.
Publicado: (2021)

Complications of Cryoballoon Pulmonary Vein Isolation
por: Shinsuke Miyazaki, et al.
Publicado: (2019)

Evaluation of low gradient severe aortic stenosis: should we change our outlook in the analysis of clinical data?
por: Ivan Corazza, et al.
Publicado: (2021)

Metabolic endophenotype associated with right ventricular glucose uptake in pulmonary hypertension
por: Samar Farha, et al.
Publicado: (2021)

Hypotensive Action of Melatonin in Patients with Arterial Hypertension
por: E Ahsanova, et al.
Publicado: (2020)